ProstaLund AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PLUN.ST research report →
Companywww.prostalund.se
ProstaLund AB (publ) develops and sells urological devices for the treatment of patients with benign prostatic hyperplasia (BPH) in Sweden and internationally. The company also offers CoreTherm, a heat treatment of BPH; and Gepan instill for the treatment of chronic bladder inflammation. Its products are used in hospitals and clinics.
- CEO
- Anders Kristensson
- IPO
- 2013
- Employees
- 9
- HQ
- Lund, SE
Price Chart
Valuation
- Market Cap
- $775.55K
- P/E
- -0.33
- P/S
- 0.06
- P/B
- 0.14
- EV/EBITDA
- -0.16
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 68.12%
- Op Margin
- -167.04%
- Net Margin
- -169.26%
- ROE
- -41.56%
- ROIC
- -40.63%
Growth & Income
- Revenue
- $13.72M · -38.19%
- Net Income
- $-22,631,000 · -33.05%
- EPS
- $-0.56 · -124.00%
- Op Income
- $-22,490,000
- FCF YoY
- -9.30%
Performance & Tape
- 52W High
- $11.88
- 52W Low
- $0.15
- 50D MA
- $0.76
- 200D MA
- $3.22
- Beta
- 0.26
- Avg Volume
- 277.65K
Get TickerSpark's AI analysis on PLUN.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PLUN.ST Coverage
We haven't published any research on PLUN.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PLUN.ST Report →